Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
The mRNA vaccines have been considered effective for combating cancer. However, the core components of the mRNA vaccines against head and neck squamous cell carcinoma (HNSCC) and the effects remain unclear. Our study aims to identify effective antigens in HNSCC to develop mRNA vaccines for correspon...
Main Authors: | Yan Chen, Ning Jiang, Meihua Chen, Baiyan Sui, Xin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1064754/full |
Similar Items
-
Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma
by: Hong-Xia Li, et al.
Published: (2022-12-01) -
The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease
by: Yangju Fu, et al.
Published: (2023-08-01) -
Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
by: Lang Li, et al.
Published: (2023-09-01) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
by: Cong Liu, et al.
Published: (2022-01-01) -
Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development
by: Zhuohui Chen, et al.
Published: (2022-07-01)